New Weight-Loss Drug Aims for Results Without Harsh GI Effects
July 2, 2025
A new dual agonist GLP-1 is showing weight loss without gastrointestinal side effects and appetite suppression. We speak with the company to learn more.
3 min read
False
July 2, 2025
A new dual agonist GLP-1 is showing weight loss without gastrointestinal side effects and appetite suppression. We speak with the company to learn more.
3 min read
June 30, 2025
We ask experts for their views on the GLP-1 market in this exclusive eBook.
1 min read
June 9, 2025
We explore how AI-based tools are making a mark in formulation by improving solubility
10 min read
By Rob Coker
June 4, 2025
Recent developments in the treatment of psoriasis has brought new hope to sufferers, and a surge in market standings.
4 min read
By Stephanie Vine
May 30, 2025
From different modalities to overcoming aggregation; we find out what advances are affecting the development of ADCs.
3 min read
By Stephanie Vine
May 16, 2025
Biotech company Ethris explains the benefits and challenges of developing spray dried RNA vaccines.
5 min read
By Stephanie Vine
May 7, 2025
Researchers say they have found a method that will allow some large molecules to be administered orally
2 min read
By Stephanie Vine
May 6, 2025
What’s going on in nasal drug delivery? We spoke with Kim Earnst, VP of product development and laboratory service at Renaissance Lakewood to get a glimpse of the latest trends and challenges in the area.
3 min read
By Stephanie Vine
April 21, 2025
In Part 1 of our interview with Simon Tasker, he explained how he joined Colorcon as a bench chemist – and never left...
5 min read
By Stephanie Vine
April 3, 2025
Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally
4 min read
False
False
False